|
1
|
Marlu R, Malvezzi P, Seyve L, Jouve T,
Maurizi J, Defendi F, Carron PL, Christophe M, Le Gouellec A,
Polack B and Rostaing L: Effect of double-filtration plasmapheresis
for antibody-mediated rejection on hemostasis parameters and
thrombin generation. Thromb Res. 166:113–121. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Stucker F, Ponte B, Tataw J, Martin PY,
Wozniak H, Pugin J and Saudan P: Efficacy and safety of
citrate-based anticoagulation compared to heparin in patients with
acute kidney injury requiring continuous renal replacement therapy:
A randomized controlled trial. Crit Care. 19(91)2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Peng X, Xie X, Yin J, Yu S, Zhang C and
Zhao S: Anticoagulation effect and safety observation of regional
citrate anticoagulation for double-filtration plasmapheresis in
critical patients. Blood Purif. 49:542–549. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mcgeoch L, Twilt M, Famorca L, Bakowsky V,
Barra L, Benseler SM, Cabral DA, Carette S, Cox GP, Dhindsa N, et
al: CanVasc recommendations for the management of antineutrophil
cytoplasm antibody-associated vasculitides. J Rheumatol. 43:97–120.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bloch DA, Michel BA, Hunder GG, McShane
DJ, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Fries JF,
Leavitt RY, et al: The American College of Rheumatology 1990
criteria for the classification of vasculitis, patients and
methods. Arthritis Rheum. 33:1068–1073. 1990.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jennette JC, Falk RJ, Bacon PA, Basu N,
Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen
EC, et al: 2012 revised international Chapel Hill consensus
conference nomenclature of vasculitides. Arthritis Rheum. 65:1–11.
2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yates M, Watts RA, Bajema IM, Cid MC,
Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA,
et al: EULAR/ERA-EDTA recommendations for the management of
ANCA-associated vasculitis. Ann Rheum Dis. 75:1583–1594.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Choi HK, Liu SM, Merkel PA, Colditz GA and
Niles JL: Diagnostic performance of antineutrophil cytoplasmic
antibody tests for idiopathic vasculitides: Metaanalysis with a
focus on antimyeloperoxidase antibodies. J Rheumatol. 28:1584–1590.
2001.PubMed/NCBI
|
|
9
|
Mohammad AJ, Mortensen KH, Babar J, Smith
R, Jones RB, Nakagomi D, Sivasothy P and Jayne DRW: Pulmonary
involvement in antineutrophil cytoplasmic antibodies
(ANCA)-associated vasculitis: The influence of ANCA Subtype. J
Rheumatol. 44:1458–1467. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jayne DR, Gaskin G, Rasmussen N,
Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO,
Sinico RA, Stegeman CA, et al: Randomized trial of plasma exchange
or high-dosage methylprednisolone as adjunctive therapy for severe
renal vasculitis. J Am Soc Nephrol. 18:2180–2188. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Walsh M, Catapano F, Szpirt W, Thorlund K,
Bruchfeld A, Guillevin L, Haubitz M, Merkel PA, Peh CA, Pusey C and
Jayne D: Plasma exchange for renal vasculitis and idiopathic
rapidly progressive glomerulonephritis: A meta-analysis. Am J
Kidney Dis. 57:566–574. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Walsh M, Merkel PA, Peh CA, Szpirt WM,
Puéchal X, Fujimoto S, Hawley CM, Khalidi N, Floßmann O, Wald R, et
al: Plasma exchange and glucocorticoids in severe ANCA-Associated
vasculitis. N Engl J Med. 382:622–631. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kidney Disease: Improving Global Outcomes
(KDIGO) Glomerular Diseases Work Group: KDIGO 2021 clinical
practice guideline for the management of glomerular diseases.
Kidney Int. 100:S1–S276. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fabbri LP, Nucera M, Malyan MA and Becchi
C: Regional anticoagulation and antiaggregation for CVVH in
critically ill patients: A prospective, randomized, controlled
pilot study. Acta Anaesthesiol Scand. 54:92–97. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Biancofiore G, Esposito M, Bindi L,
Stefanini A, Bisà M, Boldrini A, Consani G, Filipponi F and Mosca
F: Regional filter heparinization for continuous veno-venous
hemofiltration in liver transplant recipients. Minerva Anestesiol.
69:527–534, 534-8. 2003.PubMed/NCBI(In English, Italian).
|
|
16
|
Carr JA and Silverman NJ: The
heparin-protamine interaction. A review. Cardiovasc Surg (Torino).
40:659–666. 1999.PubMed/NCBI
|
|
17
|
KDIGO AKI: Kidney Disease Improving Global
Outcomes. AKI Work Group: Clinical Practice Guideline for Acute
Kidney Injury. Kidney International, pp1-138, 2012.
|
|
18
|
Gattas DJ, Rajbhandari D, Bradford C, Buhr
H, Lo S and Bellomo R: A randomized controlled trial of regional
citrate versus regional heparin anticoagulation for continuous
renal replacement therapy in critically Ill adults. Crit Care Med.
43:1622–1629. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Buturovic-Ponikvar J: Is regional citrate
anticoagulation the future of hemodialysis? Ther Apher Dial.
20:234–239. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Janssen MJ, Huijgens PC, Bouman AA, Oe PL
and van der Meulen J: Citrate anticoagulation and divalent cations
in hemodialysis. Blood Purif. 12:308–316. 1994.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Webb AR, Mythen MG, Jacobson D and Mackie
IJ: Maintaining blood flow in the extracorporeal circuit:
Haemostasis and anticoagulation. Intensive Care Med. 21:84–93.
1995.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Brandl M, Strobl K, Hartmann J, Kellner K,
Posnicek T and Falkenhagen D: A target-orientated algorithm for
regional citrate-calcium anticoagulation in extracorporeal
therapies. Blood Purif. 33:7–20. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kang JW, Seo DH, Oh YC, LEE HJ and KIM SI:
A case of a large fibrin clot formed in a plama unit collected by
donor plasmapheresis. Korean J Blood Trans. 11:183–187. 2000.
|
|
24
|
Kissling S, Legallais C, Pruijm M, Teta D,
Vogt B, Burnier M, Rondeau E and Ridel C: A new prescription model
for regional citrate anticoagulation in therapeutic plasma
exchanges. BMC Nephrol. 18(81)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yin Z, Xu Z, Zhu Q, Liu J, Qian J, You H,
Gu Y, Hao C, Jiao Z and Ding F: Citrate pharmacokinetics in
critically Ill patients with acute kidney injury. PLoS One.
8(e65992)2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wen M, Küchle C, Steubl D, Satanovskji R,
Heemann U, Suttmann Y, Angermann S, Kemmner S, Rehbehn L, Huber M,
et al: A novel citrate-based protocol versus heparin
anticoagulation for sustained low-efficiency dialysis in the ICU:
Safety, efficacy, and cost. BMC Nephrol. 19(79)2018.PubMed/NCBI View Article : Google Scholar
|
